With a total investment of $3.2 billion, FUJIFILM Diosynth Biotechnologies continues to expand its Large-Scale Cell Culture CMDO Business in Holly Springs, North Carolina, located on the southwestern outskirts of metro Raleigh between Apex and Fuquay-Varina. Last week, the company announced it would build upon the $2 billion expansion investment made in 2021. As a result of the additional $1.9 billion funding, FUJIFILM adds a new cell culture facility which will include eight 20,000-liter mammalian cell culture bioreactors for bulk drug substance. The addition allows for the company to house a number of new projects and, once complete, will make the site one of the largest cell culture biopharmaceutical CDMO facilities in North America. By 2031, the project will create a total of 1,400 new jobs in the region.
|